Association of a polymorphism in the monocyte chemoattractant protein-1/CCL2 gene and lupus nephritis in systemic lupus erythematosus patients

Clinical and Experimental Rheumatology

Volumn 26, Issue 5, 2008, Pages 972-973

  Hoshi, D ^a   Okamoto, Hiroshi ^a   Kaneko, H ^a   Ichikawa, N ^a   Terai, C ^a   Yamanaka, H ^a   Kamatani, N ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; GUANINE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE FREQUENCY; GENE FUNCTION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; JAPANESE; KIDNEY BIOPSY; LETTER; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; NEUROPSYCHIATRIC SYNDROME OF SYSTEMIC LUPUS ERYTHEMATOSUS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHEMOKINE CCL2; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS NEPHRITIS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 57249111620     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. ACR AD HOC COMMITTEE ON NEUROPSYCHIATRIC LUPUS NOMENCLATURE: The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.
2. WILSON AG, SYMONS JA, MCDOWELL TL, MCDEVITT HO, DUFF GW: Effects of a polymorphism in the human tumor necrosis factor promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-9.
3. LAZARUS M, HAJEER AH, TURNER D et al.: Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol 1997; 24: 2314-7.
4. SALMON JE, MILLARD S, SCHACHTER LA et al.: FcRIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 1996; 97: 1348-54.
5. ROVIN BH, LU L, ZHANG X: A novel interleukin-8 polymorphism is associated with severe systemic lupus erythematosus nephritis. Kidney Int 2002; 62: 261-5.
6. TUCCI M, BARNES EV, SOBEL ES, CROKER BP, SEGAL MS, REEVES WH, RICHARDS HB: Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis. Arthritis Rheum 2004; 50: 1842-9.
7. LIAO CH, YAO TC, CHUNG HT, SEE LC, KUO ML, HUANG JL: Polymorphisms in the promoter region of RANTES and the regulatory region of monocyte chemoattractant protein-1 among Chinese children with systemic lupus erythematosus. J Rheumatol 2004; 31: 2062-7.
8. BROWN KS, NACKOS E, MORTHALA S, JENSEN LE, WHITEHEAD AS, VON FELDT JM: Monocyte chemoattractant protein-1: Plasma concentrations and A(-2518)G promoter polymorphism of its gene in systemic lupus erythematosus. J Rheumatol 2007; 34: 740-6.
9. IKARI K, MOMOHARA S, INOUE E et al. Haplo-type analysis revealed no association between the PTPN22 gene and RA in a Japanese population. Rheumatology (Oxford) 2006; 45: 1345-8.
10. IIKUNI N, OKAMOTO H, YOSHIO T et al.: Raised monocyte chemoattractant protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus. Ann Rheum Dis 2006; 65: 253-6.